Insights
Report Library
Browse our full archive of reports. Filter by health area, disease or condition, product, and date. Written by our expert analysts, our reports highlight key messages in the data, make the case for change and offer actionable recommendations.
-3-404x404.webp)
10 min read
Bridging the gap: advancing inclusive research for pregnant and lactating women in global health R&D
Pregnant and lactating women have long been excluded from clinical research. This report seeks to characterise the extent of the evidence gap, focusing on HIV/AIDS, malaria and Zika.
10 min read
Unveiling the hidden crisis in women’s health: a deep dive into women’s pain, endometriosis & uterine fibroids
Despite chronic pain conditions which are exclusive to women, such as endometriosis and uterine fibroids, women’s pain is frequently misdiagnosed, underestimated or dismissed altogether.
45 min read
G-FINDER 2024 Landscape of Emerging Infectious Disease Research & Development report: Lessons Learned
This is our third report analysing global investment into research and development for emerging infectious diseases
10 min read
Mpox Breakdown: Cash, Strategy, and the Fight Ahead
The scale of the current Mpox outbreak and its impact on vulnerable populations highlight the need for coordinated efforts to mitigate the crisis and prevent further spread.
20 min read
The Drug Drought in Maternal Health: an Ongoing Predicament
We publish in The Lancet Global Health on the striking lack of innovation for pregnancy-related conditions
-404x269.webp)
Methodology & assumptions for the Impact of Global Health R&D report
The methodology and the assumptions we used to develop the Impact of Global Health R&D report
Download
An explainer of our ROI calculations for the Impact of Global Health R&D report
How we calculated ROI for our Impact of Global Health R&D report
Download
45 min read
The Impact of Global Health R&D
Investing in global health R&D pays off. It yields a high health and economic return to society. For every dollar spent, there is a societal return of $405. This is not just a good case for investment, but an outstanding one.
20 min read
Landscape of Diagnostics Development for Preterm Labour, Pre-eclampsia & Intrauterine Growth Restriction
With PTL, PE and IUGR still posing major health threats mothers and babies, this report is encouraged to see a relatively large number of diagnostics being developed or refined for use
You may also be interested in
BROWSE OUR
Hubs
Your destination for a curated collection of data, insights and tools on the most pressing global health topics. Explore our hubs on Women’s Health, the Impact of Global Health R&D, and more to launch in the future.
BROWSE BY
Health Areas
Our Health Areas resource gives you an at-a-glance summary of the state of innovation and annual R&D investment by disease and condition. Updated regularly, this is a unique quick reference for the global health community.